Milde, T., Oehme, I., Korshunov, A., Kopp-Schneider, A., Remke, M., Northcott, P., . . . Witt, O. (2010). HDAC5 and HDAC9 in medulloblastoma: Novel markers for risk stratification and role in tumor cell growth. Clinical cancer research, 16(12), . https://doi.org/10.1158/1078-0432.CCR-10-0395
Chicago-Zitierstil (17. Ausg.)Milde, Till, et al. "HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth." Clinical Cancer Research 16, no. 12 (2010). https://doi.org/10.1158/1078-0432.CCR-10-0395.
MLA-Zitierstil (9. Ausg.)Milde, Till, et al. "HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth." Clinical Cancer Research, vol. 16, no. 12, 2010, https://doi.org/10.1158/1078-0432.CCR-10-0395.